●
SRPT
Sarepta Therapeutics, Inc.
$3.70M
Single buy
Discretionary Insider Activity
Date:
08/10/2023
Insiders:
Chambers Michael Andrew, director
Prior trend:
9 months of no clear discretionary insider activity

Summary

A $3.70M single buy for Sarepta Therapeutics, Inc. (SRPT) on 08/10/2023 after 9 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $3.70M 08/11/2023 Chambers Michael Andrew Director 0001209191-23-045366

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $231K 08/10/2023 Chambers Michael Andrew Common Stock Discretionary Purchase
● Buy $116K 08/10/2023 Chambers Michael Andrew Common Stock Discretionary Purchase
● Buy $3.35M 08/10/2023 Chambers Michael Andrew Common Stock Discretionary Purchase

Stats

Prior max multiple:
39.2
Prior median multiple:
39.2

Metadata

Signal ID:
NTDfIIcOX8LZFuGx
Detected on:
08/09/2023